{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:40:40Z","timestamp":1789641640806,"version":"4.0.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,31]]},"DOI":"10.7759\/cureus.89183","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:47:21Z","timestamp":1754030841000},"source":"Crossref","is-referenced-by-count":1,"title":["GLP-1 Receptor Agonist Use in Patients Undergoing Distal Radius Fracture Surgery: A Retrospective Review of Perioperative Considerations"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Khak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah A","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hozien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif M","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020786","article-title":"Metabolic Syndrome: Updates on Pathophysiology and Management in 2021","volume":"23","author":"Fahed G","year":"2022","unstructured":"Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022, 23:10.3390\/ijms23020786","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101882","article-title":"Pharmacotherapy of obesity: an update on the available medications and drugs under investigation","volume":"58","author":"Chakhtoura M","year":"2023","unstructured":"Chakhtoura M, Haber R, Ghezzawi M, Rhayem C, Tcheroyan R, Mantzoros CS. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation. EClinicalMedicine. 2023, 58:101882. 10.1016\/j.eclinm.2023.101882","journal-title":"EClinicalMedicine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2023.10.002","article-title":"Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022","volume":"64","author":"Watanabe JH","year":"2024","unstructured":"Watanabe JH, Kwon J, Nan B, Reikes A. Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022. J Am Pharm Assoc (2003). 2024, 64:133-8. 10.1016\/j.japh.2023.10.002","journal-title":"J Am Pharm Assoc (2003)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.462","article-title":"Glucagon-like peptide agonists: A prospective review","volume":"7","author":"Mariam Z","year":"2024","unstructured":"Mariam Z, Niazi SK. Glucagon-like peptide agonists: A prospective review. Endocrinol Diabetes Metab. 2024, 7:e462. 10.1002\/edm2.462","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.23.00167","article-title":"Glucagon-like Peptide-1 Agonists: What the Orthopaedic Surgeon Needs to Know","volume":"12","author":"Chan PY","year":"2024","unstructured":"Chan PY, Mika AP, Martin JR, Wilson JM. Glucagon-like Peptide-1 Agonists: What the Orthopaedic Surgeon Needs to Know. JBJS Rev. 2024, 12:10.2106\/JBJS.RVW.23.00167","journal-title":"JBJS Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-024-11263-2","article-title":"Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"39","author":"Kindel TL","year":"2025","unstructured":"Kindel TL, Wang AY, Wadhwa A, et al.. Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Endosc. 2025, 39:180-3. 10.1007\/s00464-024-11263-2","journal-title":"Surg Endosc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz323","article-title":"Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes","volume":"116","author":"Heuvelman VD","year":"2020","unstructured":"Heuvelman VD, Van Raalte DH, Smits MM. Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes. Cardiovasc Res. 2020, 116:916-30. 10.1093\/cvr\/cvz323","journal-title":"Cardiovasc Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2024.116119","article-title":"A systematic review of the use of GLP-1 receptor agonists in surgery","volume":"240","author":"Ihnat JM","year":"2025","unstructured":"Ihnat JM, De Baun H, Carrillo G, Dony A, Mukherjee TJ, Ayyala HS. A systematic review of the use of GLP-1 receptor agonists in surgery. Am J Surg. 2025, 240:116119. 10.1016\/j.amjsurg.2024.116119","journal-title":"Am J Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia","volume":"159","author":"Sen S","year":"2024","unstructured":"Sen S, Potnuru PP, Hernandez N, Goehl C, Praestholm C, Sridhar S, Nwokolo OO. Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia. JAMA Surg. 2024, 159:660-7. 10.1001\/jamasurg.2024.0111","journal-title":"JAMA Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199301000-00010","article-title":"Clinical significance of pulmonary aspiration during the perioperative period","volume":"78","author":"Warner MA","year":"1993","unstructured":"Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology. 1993, 78:56-62. 10.1097\/00000542-199301000-00010","journal-title":"Anesthesiology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19574","article-title":"Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss","volume":"330","author":"Sodhi M","year":"2023","unstructured":"Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M. Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. JAMA. 2023, 330:1795-7. 10.1001\/jama.2023.19574","journal-title":"JAMA"},{"key":"ref12","unstructured":"American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. (2023). https.\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2023\/06\/american-society-of-anesthesiologists-consensus-based-...."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12824","article-title":"Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials","volume":"19","author":"Bettge K","year":"2017","unstructured":"Bettge K, Kahle M, Abd El Aziz MS, Meier JJ, Nauck MA. Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials. Diabetes Obes Metab. 2017, 19:336-47. 10.1111\/dom.12824","journal-title":"Diabetes Obes Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97233","article-title":"Discovery, characterization, and clinical development of the glucagon-like peptides","volume":"127","author":"Drucker DJ","year":"2017","unstructured":"Drucker DJ, Habener JF, Holst JJ. Discovery, characterization, and clinical development of the glucagon-like peptides. J Clin Invest. 2017, 127:4217-27. 10.1172\/JCI97233","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOSGlobal-D-24-00148","article-title":"Glucagon-Like Peptide-1 Agonists in Total Hip Arthroplasty: Complications, Readmissions, and Patient-Reported Outcomes","volume":"8","author":"Magaldi RJ","year":"2024","unstructured":"Magaldi RJ, Strecker SE, Witmer D. Glucagon-Like Peptide-1 Agonists in Total Hip Arthroplasty: Complications, Readmissions, and Patient-Reported Outcomes. J Am Acad Orthop Surg Glob Res Rev. 2024, 8:e24.00148. 10.5435\/JAAOSGlobal-D-24-00148","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira SQ","year":"2023","unstructured":"Silveira SQ, da Silva LM, de Campos Vieira Abib A, et al.. Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth. 2023, 87:111091. 10.1016\/j.jclinane.2023.111091","journal-title":"J Clin Anesth"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000005516","article-title":"Injectable Weight Loss Medications in Plastic Surgery: What We Know, Perioperative Considerations, and Recommendations for the Future","volume":"12","author":"O'Neill ES","year":"2024","unstructured":"O'Neill ES, Wiegmann AL, Parrella N, Pittman T, Hood K, Kurlander D. Injectable Weight Loss Medications in Plastic Surgery: What We Know, Perioperative Considerations, and Recommendations for the Future. Plast Reconstr Surg Glob Open. 2024, 12:e5516. 10.1097\/GOX.0000000000005516","journal-title":"Plast Reconstr Surg Glob Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/392385-glp-1-receptor-agonist-use-in-patients-undergoing-distal-radius-fracture-surgery-a-retrospective-review-of-perioperative-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:47:24Z","timestamp":1754030844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/392385-glp-1-receptor-agonist-use-in-patients-undergoing-distal-radius-fracture-surgery-a-retrospective-review-of-perioperative-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.89183","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}